Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-15 Purchase | 2023-11-17 5:03 pm | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 13,000 | $3.906 | $50,778 | 36,472 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Tax Withholding | 2024-10-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 84 | $1.88 | 131,567 (Direct) | View |
| 2024-09-30 Tax Withholding | 2024-10-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 109 | $1.88 | 133,494 (Direct) | View |
| 2024-09-30 Tax Withholding | 2024-10-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 685 | $1.88 | 496,696 (Direct) | View |
| 2024-09-30 Tax Withholding | 2024-10-02 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 105 | $1.88 | 149,026 (Direct) | View |
| 2024-07-01 Tax Withholding | 2024-07-03 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 92 | $1.92 | 131,651 (Direct) | View |
| 2024-07-01 Tax Withholding | 2024-07-03 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 138 | $1.92 | 133,603 (Direct) | View |
| 2024-07-01 Tax Withholding | 2024-07-03 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 143 | $1.92 | 149,131 (Direct) | View |
| 2024-07-01 Tax Withholding | 2024-07-03 4:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 935 | $1.92 | 497,654 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:30 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 4,429 | $2.159 | 498,589 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:08 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CHIEF FINANCIAL OFFICER | 94 | $3.08 | 131,743 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:06 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 157 | $3.08 | 133,741 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:04 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya CHIEF LEGAL OFFICER AND GC | 161 | $3.08 | 149,274 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:02 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David PRESIDENT AND CEO | 1,004 | $3.08 | 494,160 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:22 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 62,500 | $0 | 194,337 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-03 5:22 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 93 | $2.28 | 194,337 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:21 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 62,500 | $0 | 196,398 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-03 5:21 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 157 | $2.28 | 196,398 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:20 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 62,500 | $0 | 211,935 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-03 5:20 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 161 | $2.28 | 211,935 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:17 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 225,000 | $0 | 720,164 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-03 5:17 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 1,004 | $2.28 | 720,164 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:14 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:13 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:11 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:10 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:09 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:07 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Borowski Christine Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:11 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 62,500 | $0 | 131,930 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:10 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 62,500 | $0 | 134,055 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:09 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 62,500 | $0 | 149,596 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:08 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 225,000 | $0 | 496,168 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:06 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:05 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:04 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:02 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Basta Steven L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:01 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-11-30 Option Award | 2023-12-04 4:30 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 2,284 | $2.8135 | 46,168 (Direct) | View |
Ownership | 2023-11-13 08:30 am | N/A N/A | VYNE Therapeutics Inc. | VYNE | AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 0 | $0 | 8,909,033 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 4:26 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer | 1,087 | $3.83 | 6,930 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 4:23 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,184 | $3.83 | 9,055 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 4:21 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC | 1,154 | $3.83 | 24,596 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 4:19 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO | 8,549 | $3.83 | 43,884 (Direct) | View |